Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Licenses Invader, Cleavase to Aclara

NEW YORK, Oct. 16 - Aclara will incorporate with its eTag platform Third Wave Technologies' Invader product and Cleavase enzyme for research use and gene-expression assays, the companies said today.

 

Click here for more information.

 

Separately today, Aclara said that President and CEO Joseph Limber will leave his posts on Dec. 1, and that Sharat Singh has been prooted to senior vice president of the eTag assay technology business.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.